4D Molecular Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 08/14/2025 | 4.63 M | $17.17 M | 1.49% | 8.28% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2025 | 4.56 M | $16.93 M | 0.00% | 8.16% |
| BLACKROCK, INC. | 08/12/2025 | 4.01 M | $14.88 M | -11.80% | 7.17% |
| VANGUARD GROUP INC | 08/11/2025 | 2.74 M | $10.15 M | -0.76% | 4.89% |
| NOVO HOLDINGS A/S | 08/14/2025 | 2.00 M | $7.42 M | 2.56% | 3.58% |
| JANUS HENDERSON GROUP PLC | 08/14/2025 | 1.75 M | $6.51 M | -7.27% | 3.14% |
| FEDERATED HERMES, INC. | 08/13/2025 | 1.67 M | $6.19 M | 33.37% | 2.98% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 1.48 M | $5.50 M | -9.20% | 2.65% |
| STATE STREET CORP | 08/14/2025 | 961.96 K | $3.57 M | -6.42% | 1.72% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 918.53 K | $3.41 M | -4.64% | 1.64% |
| BANK OF AMERICA CORP /DE/ | 08/14/2025 | 897.07 K | $3.33 M | 28.46% | 1.60% |
| JPMORGAN CHASE & CO | 08/12/2025 | 888.02 K | $3.29 M | 0.15% | 1.59% |
| TWO SIGMA ADVISERS, LP | 08/14/2025 | 743.40 K | $2.76 M | 51.59% | 1.33% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/11/2025 | 648.83 K | $2.41 M | -0.33% | 1.16% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2025 | 531.16 K | $1.97 M | 15.11% | 0.95% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/14/2025 | 514.61 K | $1.91 M | -2.40% | 0.92% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2025 | 455.47 K | $1.69 M | 54.72% | 0.81% |
| ACADIAN ASSET MANAGEMENT LLC | 08/07/2025 | 330.59 K | $1.23 M | -17.48% | 0.59% |
| NORTHERN TRUST CORP | 08/13/2025 | 328.98 K | $1.22 M | -13.64% | 0.59% |
| PEAPOD LANE CAPITAL LLC | 07/31/2025 | 318.54 K | $1.18 M | 62.64% | 0.57% |
| ARMISTICE CAPITAL, LLC | 08/14/2025 | 300.00 K | $1.11 M | 0.00% | 0.54% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2025 | 295.04 K | $1.09 M | 4.34% | 0.53% |
| MARSHALL WACE, LLP | 08/13/2025 | 257.62 K | $955.77 K | 62.75% | 0.46% |
| DECHENG CAPITAL LLC | 08/13/2025 | 239.51 K | $888.58 K | -28.61% | 0.43% |
| DEUTSCHE BANK AG\ | 08/12/2025 | 226.94 K | $841.94 K | -3.90% | 0.41% |
| PRIVIUM FUND MANAGEMENT B.V. | 07/30/2025 | 197.46 K | $819.45 K | 50.73% | 0.35% |
| JANE STREET GROUP, LLC | 08/14/2025 | 190.37 K | $706.28 K | 35.13% | 0.34% |
| ROYAL BANK OF CANADA | 08/14/2025 | 172.73 K | $640.00 K | 37,045.81% | 0.31% |
| PERIGON WEALTH MANAGEMENT, LLC | 07/16/2025 | 146.13 K | $542.15 K | 0.00% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 08/05/2025 | 141.10 K | $523.48 K | 4.64% | 0.25% |
| INVESCO LTD. | 08/13/2025 | 140.33 K | $520.61 K | 19.15% | 0.25% |
| MAN GROUP PLC | 08/14/2025 | 134.93 K | $500.60 K | 159.72% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 124.80 K | $463.00 K | 76.47% | 0.22% |
| GSA CAPITAL PARTNERS LLP | 07/22/2025 | 117.72 K | $437.00 K | 100.00% | 0.21% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 116.55 K | $432.41 K | 496.09% | 0.21% |
| REDMILE GROUP, LLC | 08/14/2025 | 112.17 K | $416.14 K | -88.75% | 0.20% |
| BARCLAYS PLC | 08/14/2025 | 111.78 K | $415.00 K | 15.19% | 0.20% |
| NUVEEN, LLC | 08/12/2025 | 100.71 K | $373.62 K | -33.00% | 0.18% |
| UBS GROUP AG | 08/14/2025 | 96.52 K | $358.09 K | -59.18% | 0.17% |
| XTX TOPCO LTD | 08/12/2025 | 78.58 K | $291.53 K | 100.00% | 0.14% |
| RHUMBLINE ADVISERS | 08/12/2025 | 65.96 K | $244.69 K | -6.84% | 0.12% |
| BNP PARIBAS ARBITRAGE, SNC | 08/14/2025 | 63.91 K | $237.12 K | 128.54% | 0.11% |
| FMR LLC | 08/14/2025 | 62.07 K | $230.26 K | 689.04% | 0.11% |
| SKOPOS LABS, INC. | 08/14/2025 | 56.86 K | $210.96 K | 1,248.42% | 0.10% |
| DIMENSIONAL FUND ADVISORS LP | 08/12/2025 | 55.94 K | $207.74 K | -24.98% | 0.10% |
| NORGES BANK | 08/13/2025 | 54.22 K | $201.15 K | 100.00% | 0.10% |
| SQUAREPOINT OPS LLC | 08/27/2025 | 52.88 K | $196.18 K | 100.00% | 0.09% |
| HSBC HOLDINGS PLC | 08/13/2025 | 51.17 K | $192.40 K | -1.92% | 0.09% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2025 | 48.81 K | $181.09 K | 11.48% | 0.09% |
| HRT FINANCIAL LP | 08/14/2025 | 43.90 K | $162.00 K | -12.89% | 0.08% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
4D Molecular Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 146 institutional investors and hedge funds held shares of 4D Molecular Therapeutics, Inc.. The most heavily invested institutionals were:
Assenagon Asset Management S.A.: 663,657
Perigon Wealth Management, LLC: 146,133
HARBOR CAPITAL ADVISORS, INC.: 11,901
LOS ANGELES CAPITAL MANAGEMENT LLC: 11,280
Farther Finance Advisors, LLC: 4,952
CWM, LLC: 4,922
62.60% of 4D Molecular Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 40.09 M shares in the last 24 months. This purchase volume represents approximately $450.66 M in transactions.